Clinical Trial

The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis

Recruiting
View on ClinicalTrials.gov →
Summary
The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-04-29; most recent amendment 2025-05-14.
Trial Details
NCT Number NCT04368663
Lead Sponsor Showa Inan General Hospital
Conditions Pneumatosis Cystoides Intestinalis
Enrollment 100 participants
Start Date 2020-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-11